Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Airport wait times won't return to normal until Congress reaches a deal to pay TSA. Here's why they still can't come to an agreement. - 2Artemis II astronauts are more than halfway to the moon as they seek to break Apollo 13's record
- 3Report: Russian military pressuring students to work as drone pilots
- 4Progress Over Perfection: Lessons From Garment Factories Fighting Heat Stress
- 5Become the best at Discussion: 6 Procedures for Progress
- Why More Couples Are Choosing Africa For Their Honeymoon
- The new queen of country music has no scandals and no gimmicks — and just broke a record set by Taylor Swift
- Watch South Korean startup Innospace attempt its 1st-ever orbital launch today
- This country music star spent years hiding his sexuality. Coming out — and beating addiction — has made his soul feel '20 pounds lighter.'
- NASA says Maven spacecraft that was orbiting Mars has gone silent
- Careful Connections: Building Association and Trust
- The 20 Most sultry Style of the Time
- Holiday travel: Best days to hit the road as 110 million Americans expected to drive over Christmas and New Year's
- Savvy Tips for Seniors Hyundai IONIQ EV
